Vietnam Health Authorities, Merck Sharp & Dohme In Vaccine Dispute
This article was originally published in PharmAsia News
Executive Summary
Vietnam drug regulators say Merck Sharp & Dohme, maker of an MMR vaccine distributed to inoculate more than 40,000 children, refuses to correct an allegedly faulty batch. The Drug Administration of Vietnam said the measles-mumps-rubella vaccine it bought to inoculate more than 40,000 children had been mislabeled. The agency asked MSD Vietnam to correct the labels that said the drug should be injected into the muscle, but the company said the risk was not serious and that health care workers simply should be advised to inject it beneath the skin instead. The Ho Chi Minh City Department of Health said, however, the MSD response was unacceptable. The MSD representative left in the middle of a meeting with the city agency. (Click here for more
|
Vietnam drug regulators say Merck Sharp & Dohme, maker of an MMR vaccine distributed to inoculate more than 40,000 children, refuses to correct an allegedly faulty batch. The Drug Administration of Vietnam said the measles-mumps-rubella vaccine it bought to inoculate more than 40,000 children had been mislabeled. The agency asked MSD Vietnam to correct the labels that said the drug should be injected into the muscle, but the company said the risk was not serious and that health care workers simply should be advised to inject it beneath the skin instead. The Ho Chi Minh City Department of Health said, however, the MSD response was unacceptable. The MSD representative left in the middle of a meeting with the city agency. (Click here for more) "Drug Company Refuses To Cooperate With DoH" - Vietnam Bridge (3/18/09) |